TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular Edema
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether an intravitreal dexamethasone implant
(Ozurdex, Allergan) is effective to manage macular edema secondary to non-infectious uveitis.